GREEN MOUNTAIN STRATEGIES LLC DC for ALVOGEN
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals including Strategic National Stockpile appropriations and reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act; Appropriations - S.2624/HR 5894, the Fiscal Year 2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024; Implementation of H.R.2617, Consolidated Appropriations Act, 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNA KATHERINE WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.